RVPH
NASDAQ · Pharmaceuticals
Reviva Pharmaceuticals Holdi
$0.48
+0.03 (+6.12%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+2,490.6% upside
Low Target
$10.29
Average Target
$12.37
High Target
$18.62
Current Price
$0.48
Current
$0.48
$0.48
Target
$12.37
$12.37
$10.29
$12.37 avg
$18.62
Scenario Analysis
Bear Case
$10.29
2,055.0%
Low target
Base Case
$12.37
+2,490.6%
Avg target
Bull Case
$18.62
+3,799.5%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$17.20
-97.2% from high
52-Week Low
$0.26
+82.3% from low
Target vs 52W High
$12.37
-28.1% vs high
Next Earnings Report
Aug 17, 2026
8d
until earnings
EPS Est: $-0.44
Earnings in 8 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals